Integrity CE

 


 

SABCS 2023 Insights: "KEYNOTE-756 Trial - Pembro vs. Placebo Combined With Neoadjuvant Chemo and Adjuvant ET for High-Risk, Early Stage ER+, HER2- BC"

206 views
January 26, 2024
0 Comments
Login to view comments. Click here to Login
Oncology & Hematology